PM
AGIO icon

Parametrica Management’s Agios Pharmaceuticals AGIO Stock Holding History

Parametrica Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,433
Closed -$228K – 339
2017
Q2 		$228K Buy
+4,433
New +$227K 0.21% 201
2016
Q4 		– Sell
-4,658
Closed -$246K – 210
2016
Q3 		$246K Buy
+4,658
New +$203K 0.68% 73
2015
Q4 		– Sell
-4,866
Closed -$343K – 62
2015
Q3 		$343K Buy
+4,866
New +$476K 2.16% 11

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parametrica Management's AGIO Position: Q3 2017 in Review

Parametrica Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2017, closing a stake of 4,433 shares — an estimated $228K sold.

Parametrica Management first reported a position in AGIO in Q3 2015 and held it in 3 quarters. The position peaked at $343K in Q3 2015. 171 funds tracked by Wall St. Rank hold AGIO as of Q3 2017.

  • Parametrica Management reported no remaining Agios Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Parametrica Management sold 4,433 Agios Pharmaceuticals shares in Q3 2017, an estimated $228K.
  • Parametrica Management first reported a position in Agios Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • Parametrica Management's Agios Pharmaceuticals position peaked at $343K in Q3 2015.
  • 171 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2017.

Based on Parametrica Management's 13F filing for Q3 2017, filed 27 Oct 2017.